- Investing Ideas
- /
- Belgian Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Belgian Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
1
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
1 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ARGX | €595.40 | 0% | 73.3% | €36.5b | €596.31 | PS19.7x | E55.6% | n/a |
Page 1 of 1